1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Pesticide use and kidney function among farmers in the Biomarkers of Exposure and Effect in Agriculture study
    Journal Article

    Shearer, J. J.; Sandler, D. P.; Andreotti, G.; Murata, K.; Shrestha, S.; Parks, C. G.; Liu, D.; Alavanja, M. C.; Landgren, O.; Beane Freeman, L. E.; more...
    Environmental Research (2021)

    Fulltext@MSK | Save
  • CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel in relapsed/refractory multiple myeloma
    Meeting Abstract

    Madduri, D.; Berdeja, J.; Usmani, S.; Jakubowiak, A.; Agha, M.; Cohen, A.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; more...
    British Journal of Haematology (2021)

    Fulltext@MSK | Save
  • Phase I study of the CD47 blocker TTI-621 in patients with relapsed or refractory hematologic malignancies
    Journal Article

    Ansell, S. M.; Maris, M. B.; Lesokhin, A. M.; Chen, R. W.; Flinn, I. W.; Sawas, A.; Minden, M. D.; Villa, D.; Percival, M. E. M.; Advani, A. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Cellular therapy during COVID-19: Lessons learned and preparing for subsequent waves
    Journal Article

    Nawas, M. T.; Shah, G. L.; Feldman, D. R.; Ruiz, J. D.; Robilotti, E. V.; Aslam, A. A.; Dundas, M.; Kamboj, M.; Barker, J. N.; Cho, C.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
    Journal Article

    Maura, F.; Diamond, B.; Maclachlan, K. H.; Derkach, A.; Yellapantula, V. D.; Rustad, E. H.; Hultcrantz, M.; Shah, U. A.; Hong, J.; Landau, H. J.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Iceland screens, treats, or prevents multiple myeloma (iStopMM): A population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
    Journal Article

    Rögnvaldsson, S.; Love, T. J.; Thorsteinsdottir, S.; Reed, E. R.; Óskarsson, J. Þ; Pétursdóttir, Í; Sigurðardóttir, G. Á; Viðarsson, B.; Önundarson, P. T.; Agnarsson, B. A.; more...
    Blood Cancer Journal (2021)

    Fulltext@MSK | Save
  • Improving prognostic assignment in older age groups of multiple myeloma
    Meeting Abstract

    Boyle, E. M.; Litke, R. R.; Blaney, P.; Ashby, T. C.; Bauer, M.; Walker, B.; Ghamlouch, H.; Choi, J.; Perrial, E.; Wang, Y.; more...
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Minimal residual disease in multiple myeloma: Defining the role of next generation sequencing and flow cytometry in routine diagnostic use
    Review

    Maclachlan, K. H.; Came, N.; Diamond, B.; Roshal, M.; Ho, C.; Thoren, K.; Mayerhoefer, M. E.; Landgren, O.; Harrison, S.
    Pathology (2021)

    Fulltext@MSK | Save